Reteplase：Reteplase. A review of its pharmacological properties and ...
Reteplase. A review of its pharmacological properties and ...
由SNoble著作·1996·被引用105次—Reteplase(BM06.022;r-PA)isarecombinantpeptidewhichconsistsofthekringle2andproteasedomainsofhumantissue-typeplasminogenactivator.。其他文章還包含有：「RETAVASE®(reteplase)」、「Reteplase」、「Reteplase:Uses」、「ReteplaseversusAlteplaseforAcuteIschemicStroke」、「Retavase(reteplase)dosing,indications」、「Reteplase:Structure,Function」、「Reteplase」、「Rapilysin」
查看更多 離開網站
RETAVASE® (reteplase)
https://retavase.com
RETAVASE® (reteplase) is a tissue plasminogen activator (tPA) indicated for treatment of acute ST-elevation myocardial infarction (STEMI) to reduce the risk of ...
Reteplase
https://en.wikipedia.org
Reteplase, trade names include Retavase, is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them.
Reteplase: Uses
https://go.drugbank.com
Reteplase is a purified form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary ...
Reteplase versus Alteplase for Acute Ischemic Stroke
https://www.nejm.org
Reteplase is a recombinant plasminogen activator that is characterized by a double-bolus approach (the boluses are separated by 30 minutes) with ...
Retavase (reteplase) dosing, indications
https://reference.medscape.com
Acute Myocardial Infarction. 10 units IV bolus (over 2 minutes), THEN. Second dose given 30 minutes after first (for total cumulative dose of 20 units).
Reteplase: Structure, Function
https://www.ncbi.nlm.nih.gov
Reteplase is a modified nonglycosylated recombinant form of tPA used to dissolve intracoronary emboli, lysis of acute pulmonary emboli, and ...
Reteplase
https://www.sciencedirect.com
Reteplase is a second-generation nonglycosylated deletion mutant of alteplase. Reteplase is less fibrin specific than alteplase but has a longer half-life (18 ...
Rapilysin
https://ec.europa.eu
The recommended dose of heparin is 5000 I.U. given as a bolus injection prior to reteplase therapy followed by an infusion of 1000 I.U. per hour starting after ...